News

Agenus and Merck work together to advance immune-oncology programs.

Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.

The European Medicines Agency's Annual Report highlights the agency's drug approvals, projects, and initiatives for 2013.

BMS acquisition of iPierian advances BMS' pursuit of therapeutics for genetically defined diseases.

ISPE drug shortage prevention plan to address organizational strategies, manufacturing and quality systems, and supply chain quality.

Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.

Research reveals that proteins involved in autism interact with many more partners than previously known.

Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.

University of Michigan study demonstrates how a Silly Putty ingredient could advance stem cell therapies.

Genetic evidence supports role of APOBEC gene family in cancer development.

Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.

Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.

Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.

Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.

EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.

Mallinckrodt will acquire Questcor to create a diversified, high-growth specialty pharmaceuticals company.

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

ThioBridge linker technology to attach different payloads to a range of antibodies

Biotechnology developer American CryoStem and Rutgers University partner on stem-cell platform technology development.

FDA develops an assay that could speed the release of pandemic influenza vaccines.

uniQure appoints a new COO and vice president, Medical affairs.

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.